Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

AI-based OCT analysis reveals plaque composition changes after intensive lipid-lowering therapy in non-obstructive coronary lesions: YELLOW III sub-study

This YELLOW III sub-study investigates the impact of intensive lipid-lowering therapy on non-obstructive coronary plaques using AI-based tis

Study: Clopidogrel Monotherapy Linked to Lower MACE and Bleeding Risks vs. Aspirin After PCI

A nationwide cohort study published in JACC: Asia found that among stable patients who underwent PCI, transitioning to clopidogrel monothera

New 2026 Cholesterol Guidelines Shift Toward Earlier, More Personalized Heart Disease Prevention

In March 2026, the American College of Cardiology and the American Heart Association released updated cholesterol management guidelines that

Study Reveals Only 1.1% of US Adults Tested for Lipoprotein(a) Despite Guideline Recommendations

A Family Heart Database analysis presented at the 10th Annual Heart in Diabetes Meeting reveals that only 1.1% of US adults have undergone l

Las enfermedades cardiovasculares exigen vigilancia desde la mediana edad

以岭药业：厄贝沙坦化学原料药上市申请获批